Cargando…
Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis
Although endovascular stenting has been used as an interventional therapy to treat cardio- and cerebro-vascular diseases, it is associated with recurrent vascular diseases following stent thrombosis and in-stent restenosis. In this study, a metallic stent was coated with dopamine-conjugated hyaluron...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308429/ https://www.ncbi.nlm.nih.gov/pubmed/28228930 http://dx.doi.org/10.1177/2041731416683745 |
_version_ | 1782507529350152192 |
---|---|
author | Lih, Eugene Choi, Seul Gi Ahn, Dong June Joung, Yoon Ki Han, Dong Keun |
author_facet | Lih, Eugene Choi, Seul Gi Ahn, Dong June Joung, Yoon Ki Han, Dong Keun |
author_sort | Lih, Eugene |
collection | PubMed |
description | Although endovascular stenting has been used as an interventional therapy to treat cardio- and cerebro-vascular diseases, it is associated with recurrent vascular diseases following stent thrombosis and in-stent restenosis. In this study, a metallic stent was coated with dopamine-conjugated hyaluronic acid with different ratios of catechol group to improve hemocompatibility and re-endothelialization. Especially, we were interested in how much amount of catechol group is appropriate for the above-mentioned purposes. Therefore, a series of dopamine-conjugated hyaluronic acid conjugates with different ratios of catechol group were synthesized via a carbodiimide coupling reaction. Dopamine-conjugated hyaluronic acid conjugates were characterized with (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and the amount of catechol group in dopamine-conjugated hyaluronic acid was measured by ultraviolet spectrometer. Co-Cr substrates were polished and coated with various dopamine-conjugated hyaluronic acid conjugates under pH 8.5. Dopamine-conjugated hyaluronic acid amounts on the substrate were quantified by micro-bicinchoninic acid assay. Surface characteristics of dopamine-conjugated hyaluronic-acid-coated Co-Cr were evaluated by water contact angle, scanning electron microscopy, and atomic force microscopy. The hemocompatibility of the surface-modified substrates was assessed by protein adsorption and platelet adhesion tests. Adhesion and activation of platelets were confirmed with scanning electron microscopy and lactate dehydrogenase assay. Human umbilical vein endothelial cells were cultured on the substrates, and the viability, adhesion, and proliferation were investigated through cell counting kit-8 assay and fluorescent images. Obtained results demonstrated that optimal amounts of catechol group (100 µmol) in the dopamine-conjugated hyaluronic acid existed in terms of various properties such as hemocompatibility and cellular responses. |
format | Online Article Text |
id | pubmed-5308429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-53084292017-02-22 Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis Lih, Eugene Choi, Seul Gi Ahn, Dong June Joung, Yoon Ki Han, Dong Keun J Tissue Eng Original Article Although endovascular stenting has been used as an interventional therapy to treat cardio- and cerebro-vascular diseases, it is associated with recurrent vascular diseases following stent thrombosis and in-stent restenosis. In this study, a metallic stent was coated with dopamine-conjugated hyaluronic acid with different ratios of catechol group to improve hemocompatibility and re-endothelialization. Especially, we were interested in how much amount of catechol group is appropriate for the above-mentioned purposes. Therefore, a series of dopamine-conjugated hyaluronic acid conjugates with different ratios of catechol group were synthesized via a carbodiimide coupling reaction. Dopamine-conjugated hyaluronic acid conjugates were characterized with (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and the amount of catechol group in dopamine-conjugated hyaluronic acid was measured by ultraviolet spectrometer. Co-Cr substrates were polished and coated with various dopamine-conjugated hyaluronic acid conjugates under pH 8.5. Dopamine-conjugated hyaluronic acid amounts on the substrate were quantified by micro-bicinchoninic acid assay. Surface characteristics of dopamine-conjugated hyaluronic-acid-coated Co-Cr were evaluated by water contact angle, scanning electron microscopy, and atomic force microscopy. The hemocompatibility of the surface-modified substrates was assessed by protein adsorption and platelet adhesion tests. Adhesion and activation of platelets were confirmed with scanning electron microscopy and lactate dehydrogenase assay. Human umbilical vein endothelial cells were cultured on the substrates, and the viability, adhesion, and proliferation were investigated through cell counting kit-8 assay and fluorescent images. Obtained results demonstrated that optimal amounts of catechol group (100 µmol) in the dopamine-conjugated hyaluronic acid existed in terms of various properties such as hemocompatibility and cellular responses. SAGE Publications 2016-12-17 /pmc/articles/PMC5308429/ /pubmed/28228930 http://dx.doi.org/10.1177/2041731416683745 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Lih, Eugene Choi, Seul Gi Ahn, Dong June Joung, Yoon Ki Han, Dong Keun Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis |
title | Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis |
title_full | Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis |
title_fullStr | Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis |
title_full_unstemmed | Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis |
title_short | Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis |
title_sort | optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308429/ https://www.ncbi.nlm.nih.gov/pubmed/28228930 http://dx.doi.org/10.1177/2041731416683745 |
work_keys_str_mv | AT liheugene optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis AT choiseulgi optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis AT ahndongjune optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis AT joungyoonki optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis AT handongkeun optimalconjugationofcatecholgroupontohyaluronicacidincoronarystentsubstratecoatingforthepreventionofrestenosis |